Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A squamous cell carcinoma that involves the pancreas.
Biomarker and diagnostic research for squamous cell carcinoma of pancreas has been reported in the published literature.
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and procedural interventions. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
60 publications have been identified in PubMed for squamous cell carcinoma of pancreas. Research spans Case Report / Case Series (47%), Basic Science / Preclinical (17%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 28 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 10 | 17% |
Testing and diagnosis research | 8 | 13% |
Research summaries | 7 | 12% |
Clinical study results | 3 | 5% |
Disease patterns and progression | 3 | 5% |
Other research | 1 | 2% |
Lim JS (2026). [PMID: 41506747](https://pubmed.ncbi.nlm.nih.gov/41506747/). *J Obes Metab Syndr*. [Review / Meta-Analysis]
Komo T (2026). [PMID: 41685201](https://pubmed.ncbi.nlm.nih.gov/41685201/). *Surg Case Rep*. [Case Report / Case Series]
Liu Z (2026). [PMID: 39559910](https://pubmed.ncbi.nlm.nih.gov/39559910/). *Rev Esp Enferm Dig*. [Case Report / Case Series]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Shichi Y (2026). [PMID: 41918815](https://pubmed.ncbi.nlm.nih.gov/41918815/). *Oncol Lett*. [Basic Science / Preclinical]
Hu C (2026). [PMID: 41560074](https://pubmed.ncbi.nlm.nih.gov/41560074/). *Medicine (Baltimore)*. [Case Report / Case Series]
Xing B (2026). [PMID: 41534087](https://pubmed.ncbi.nlm.nih.gov/41534087/). *Cancer Res*. [Basic Science / Preclinical]
Bevere M (2026). [PMID: 42128055](https://pubmed.ncbi.nlm.nih.gov/42128055/). *Mod Pathol*. [Basic Science / Preclinical]
Shiba M (2026). [PMID: 42021092](https://pubmed.ncbi.nlm.nih.gov/42021092/). *J Med Invest*. [Case Report / Case Series]
Atasoy D (2026). [PMID: 41622468](https://pubmed.ncbi.nlm.nih.gov/41622468/). *Am J Surg Pathol*. [Basic Science / Preclinical]